NDC 70518-3155

Otezla

Apremilast

Otezla is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Remedyrepack Inc.. The primary component is Apremilast.

Product ID70518-3155_c72a8ce4-ed43-7959-e053-2995a90a2c20
NDC70518-3155
Product TypeHuman Prescription Drug
Proprietary NameOtezla
Generic NameApremilast
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2021-07-14
Marketing CategoryNDA /
Application NumberNDA205437
Labeler NameREMEDYREPACK INC.
Substance NameAPREMILAST
Active Ingredient Strength30 mg/1
Pharm ClassesPhosphodiesterase 4 Inhibitor [EPC],Phosphodiesterase 4 Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 70518-3155-0

30 POUCH in 1 BOX (70518-3155-0) > 1 TABLET, FILM COATED in 1 POUCH (70518-3155-1)
Marketing Start Date2021-07-14
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Otezla" or generic name "Apremilast"

NDCBrand NameGeneric Name
55513-137Otezlaapremilast
55513-369Otezlaapremilast
55513-485Otezlaapremilast
59572-630OTEZLAapremilast
59572-631OTEZLAapremilast
59572-632OTEZLAapremilast
70518-3155Otezlaapremilast
60219-1410APREMILASTAPREMILAST
60219-1744APREMILASTAPREMILAST

Trademark Results [Otezla]

Mark Image

Registration | Serial
Company
Trademark
Application Date
OTEZLA
OTEZLA
86109590 4598910 Live/Registered
Celgene Corporation
2013-11-04
OTEZLA
OTEZLA
86093816 4598865 Live/Registered
Celgene Corporation
2013-10-17
OTEZLA
OTEZLA
85705380 4331247 Live/Registered
Celgene Corporation
2012-08-16

© 2021 FDA.report
This site is not affiliated with or endorsed by the FDA.